semaglutide being taken off the market 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these An Ongoing Crisis: Semaglutide Shortage

Based on the reluctance of major Part D plan sponsors to participate in the BALANCE Model in 2027 under the original specifications, it appears that sponsors had insufficient data to estimate their added costs associated with covering GLP-1s for obesity

Compounding pharmacies mix their own versions of these medications to bypass manufacturing shortages or offer lower-cost options

I hope they will maintain these visits and come to us regularly to follow up on mothers and children. Ready-to-Use Therapeutic Food can restore a malnourished child to health in a matter of weeks Health volunteers also visited Jamila's house in Aroma locality to screen her daughter Amna for malnutrition

Eshkevari, Ladan, et al